{"nct_id":"NCT01471847","title":"A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab","status":"COMPLETED","status_verified_date":"2018-02","start_date":"2012-02","start_date_type":null,"primary_completion_date":"2012-06","primary_completion_date_type":"ACTUAL","completion_date":"2012-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}